Dr Reddys Valuation

RDY -- USA Stock  

USD 40.10  0.10  0.25%

Dr Reddys Laboratories owns latest Real Value of $44.3 per share. The recent price of the firm is $40.1. At this time the firm appears to be undervalued. This module computes value of Dr Reddys Laboratories from reviewing the firm fundamentals such as Shares Outstanding of 165.75 M, Number of Shares Shorted of 1.6 M and Return On Asset of 6.98  as well as analyzing its technical indicators and Probability Of Bankruptcy. In general, we advise to invest in undervalued equities and to sell out overvalued equities since in the future instruments prices and their ongoing real values will draw towards each other.
Undervalued
Today
40.10
December 5, 2019
44.30
Real Value
48.44
Upside
Dr Reddys is very steady asset. Calculation of real value of Dr Reddys Laboratories is based on 3 months time horizon. Increasing Dr Reddys Laboratories time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Horizon     30 Days    Login   to change
Dr Reddys Laboratories Ltd is currently regarded as top stock in beta category among related companies. It is currently regarded as top stock in last dividend paid category among related companies .

Valuation Basics

Dr Reddys Enterprise Value Fundamentals

Quick Ratio1.18
Earnings Quarterly Growth116.90%
Revenue Growth26.40%
Earnings Growth117.20%
Additionally take a look at Your Equity Center. Please also try My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Search macroaxis.com